| Direct effects of anti-angiogenic therapies on tumor cells: VEGF signaling T Simon, T Gagliano, G Giamas Trends in molecular medicine 23 (3), 282-292, 2017 | 86 | 2017 |
| Evaluation of spheroid 3D culture methods to study a pancreatic neuroendocrine neoplasm cell line G Bresciani, LJ Hofland, F Dogan, G Giamas, T Gagliano, MC Zatelli Frontiers in Endocrinology 10, 490539, 2019 | 78 | 2019 |
| mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids T Gagliano, M Bellio, E Gentilin, D Mole, F Tagliati, M Schiavon, ... Endocrine-Related Cancer 20 (4), 463-475, 2013 | 66 | 2013 |
| The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells ML Read, RI Seed, JCW Fong, B Modasia, GA Ryan, RJ Watkins, ... Endocrinology 155 (4), 1222-1234, 2014 | 43 | 2014 |
| LMTK3 confers chemo-resistance in breast cancer J Stebbing, K Shah, LC Lit, T Gagliano, A Ditsiou, T Wang, F Wendler, ... Oncogene 37 (23), 3113-3130, 2018 | 41 | 2018 |
| The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer. MCCJ Read ML, Seed RI, Modasia B, Kwan PP, Sharma N, Smith VE, Watkins RJ ... Mol Carcinog., 2014 | 39* | 2014 |
| PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression T Gagliano, K Shah, S Gargani, L Lao, M Alsaleem, J Chen, V Ntafis, ... The Journal of clinical investigation 130 (6), 3188-3204, 2020 | 38 | 2020 |
| Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion T Gagliano, C Filieri, M Minoia, M Buratto, F Tagliati, MR Ambrosio, ... Pituitary 16, 91-100, 2013 | 37 | 2013 |
| Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells T Gagliano, E Gentilin, K Benfini, C Di Pasquale, M Tassinari, S Falletta, ... Endocrine 47, 943-951, 2014 | 34 | 2014 |
| Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque M Coen, G Marchetti, PM Palagi, C Zerbinati, G Guastella, T Gagliano, ... The American journal of pathology 183 (3), 996-1009, 2013 | 28 | 2013 |
| Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing K Shah, T Gagliano, L Garland, T O’hanlon, D Bortolotti, V Gentili, R Rizzo, ... Oncogene 39 (39), 6172-6189, 2020 | 27 | 2020 |
| The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells D Mole, E Gentilin, A Ibanez-Costa, T Gagliano, MD Gahete, F Tagliati, ... Endocrine 50, 442-452, 2015 | 21 | 2015 |
| The structure-function relationship of oncogenic LMTK3 A Ditsiou, C Cilibrasi, N Simigdala, A Papakyriakou, L Milton-Harris, ... Science Advances 6 (46), eabc3099, 2020 | 20 | 2020 |
| Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors D Mole, T Gagliano, E Gentilin, F Tagliati, C Pasquali, MR Ambrosio, ... Endocrine Related Cancer 18 (4), 439, 2011 | 20 | 2011 |
| Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors T Gagliano, E Gentilin, F Tagliati, K Benfini, C Di Pasquale, C Feo, ... Biochemical pharmacology 98 (4), 639-648, 2015 | 19 | 2015 |
| Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro D Molè, E Gentilin, T Gagliano, F Tagliati, M Bondanelli, MR Pelizzo, ... Endocrinology 153 (5), 2088-2098, 2012 | 19 | 2012 |
| Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells E Gentilin, C Di Pasquale, T Gagliano, F Tagliati, K Benfini, MR Ambrosio, ... Molecular and Cellular Endocrinology 419, 252-258, 2016 | 18 | 2016 |
| HDACs and the epigenetic plasticity of cancer cells: Target the complexity C Brancolini, T Gagliano, M Minisini Pharmacology & Therapeutics 238, 108190, 2022 | 17 | 2022 |
| Quis custodiet ipsos custodes (who controls the controllers)? Two decades of studies on HDAC9 C Brancolini, E Di Giorgio, L Formisano, T Gagliano Life 11 (2), 90, 2021 | 17 | 2021 |
| Magmas overexpression inhibits staurosporine induced apoptosis in rat pituitary adenoma cell lines F Tagliati, T Gagliano, E Gentilin, M Minoia, D Mole, EC delgi Uberti, ... PLoS One 8 (9), e75194, 2013 | 16 | 2013 |
